Zobrazeno 1 - 10
of 30
pro vyhledávání: '"N V Zabolotnykh"'
Autor:
P K Yablonskiy, T I Vinogradova, Yu N Levashev, M V Pavlova, E K Zilber, A A Starshinova, N V Sapozhnikova, I V Chernokhaeva, L I Archakova, N V Zabolotnykh, M L Vitovskaya
Publikováno v:
Терапевтический архив, Vol 88, Iss 3, Pp 111-115 (2016)
The paper sets forth the stages of design and introduction of the new Russian tuberculosis (TB) drug perchlozon registered in the Russian Federation in 2012. Based on the results of Phases I-III clinical trials, the authors evaluate the efficacy and
Externí odkaz:
https://doaj.org/article/fb038c632bd145359e573e43d0d89e97
Autor:
A.-P. S. Shurygina, N. V. Zabolotnykh, T. I. Vinogradova, K. A. Vasilyev, Zh. V. Buzitskaya, M. A. Stukova
Publikováno v:
Инфекция и иммунитет, Vol 10, Iss 3, Pp 506-514 (2020)
Improving specific prevention of tuberculosis continues to be a top priority in phthisiology. “Prime-boost” vaccination schemes aim to maintain adequate levels of specific immunity while forming long-term protection. They are based on sequential
Externí odkaz:
https://doaj.org/article/84d500ff85fa4bf780fac9a74a68727c
Autor:
D. S. Sukhanov, T. I. Vinogradova, N. V. Zabolotnykh, A. L. Kovalenko, S. N. Vasilyeva, M. G. Romantsov
Publikováno v:
Антибиотики и Химиотерапия, Vol 56, Iss 1-2, Pp 13-17 (2020)
The hepatoprotective activity of remaxol, reamberin and ademethionine was studied on a model of the liver Injury Induced by antituberculosis drugs. The study included 30 male uninbred albino rats. The following antituberculosis drugs were used: isoni
Externí odkaz:
https://doaj.org/article/efbec254b81045a5b528dc353dd6f16b
Autor:
D. S. Sukhanov, T. I. Vinogradova, A. V. Elkin, N. V. Zabolotnykh, S. N. Vasilyeva, M. L. Vitovskaya
Publikováno v:
Антибиотики и Химиотерапия, Vol 57, Iss 1-2, Pp 17-22 (2020)
Efficacy of remaxol In complex chemotherapy of generalized drug resistant tuberculosis was studied on mice. Mycobacterium tuberculosis 5419 SPBNIIF isolated from a patient with freshey diagnosticated pulmonary tuberculosis resistant to isoniazid (10
Externí odkaz:
https://doaj.org/article/7a15c8018db44d36b462efbe2d549670
Autor:
J. A. Bespyatykh, Т. I. Vinogradova, O. A. Manicheva, N. V. Zabolotnykh, M. Z. Dogonadze, M. L. Vitovskaya, A. S. Guliaev, V. Yu. Zhuravlev, E. A. Shitikov, E. N. Ilina
Publikováno v:
Инфекция и иммунитет, Vol 9, Iss 1, Pp 173-182 (2019)
Mycobacterium tuberculosis Beijing genotype strains comprise 50–80% in Russian Federation, which are divided into the main B0/W148, CladeA, and CAO clusters based on VNTR and SNP analysis. It should be noted that such phylogenetically highly close
Externí odkaz:
https://doaj.org/article/dc7cc046fdb94b4c9cde45e95ecaab68
Autor:
I. V. Krasilnikov, T. I. Vinogradova, M. Djonovic, N. V. Zabolotnykh, S. A. Arakelov, M. Z. Dogonadze, V. G. Lunin
Publikováno v:
Genes & Cells. 17:47-55
Incomplete protection of BCG vaccines, high variability of tuberculosis strains, together with the growing antibiotic resistance of mycobacterium tuberculosis, actualize the need to develop new anti-tuberculosis vaccines. Several novel experimental c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d7802eda664602672300b3ab2391eb6
https://doi.org/10.23868/202209007
https://doi.org/10.23868/202209007
Autor:
M. L. Vitovskaya, N. V. Zabolotnykh, T. I. Vinogradova, S. N. Vasilyeva, A. S. Kaftyrev, B. M. Ariel, E. S. Kirillova, T. A. Novitskaya, S. V. Iskrovskiy, M. S. Serdobintsev
Publikováno v:
Travmatologiâ i Ortopediâ Rossii, Vol 0, Iss 3, Pp 80-87 (2013)
The effect of Roncoleukin on the recovery of the bone tissue in plastic operational defects (autobone+OsteoSet-T) on the model of experimental tuberculous osteites in 36 rabbits caused by drug resistant clinical strains of M. tuberculosis was studied
Externí odkaz:
https://doaj.org/article/2a257be8978e4ce3a5a5a20cc100453b
Autor:
T I, Vinogradova, M L, Vitovskaia, N V, Zabolotnykh, A L, Kovalenko, B M, Ariél', R A, Shchegoleva
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 77(7)
It is revealed that Roncoleukin (12.5 mg/kg, intraperitoneally, 5 injections a day), Betaleukin (0.1 mg/kg, intraperitoneally, 1 time in 3 days (5 weeks)), Bestim (0.1 mg/kg, intraperitoneally, 10 injections), cycloferon (3.6 mg/kg, intraperitoneally
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bc6597f6fc4edbbc45ec24da1af1013b
https://pubmed.ncbi.nlm.nih.gov/25322647
https://pubmed.ncbi.nlm.nih.gov/25322647
Publikováno v:
Arkhiv patologii. 76(2)
Experiments on 62 male albino outbred rats investigated the impact of 14-day use of the oral hepatotropic agents ademethionine and runihol in different doses in liver damage caused by a antituberculosis combination (HRZ). HRZ-induced liver damage was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c3d4025ab1170f803382818a390b7072
https://pubmed.ncbi.nlm.nih.gov/25051722
https://pubmed.ncbi.nlm.nih.gov/25051722
Autor:
D S, Sukhanov, T I, Vinogradova, N V, Zabolotnykh, S V, Okovityĭ, S N, Vasil'eva, M L, Vitovskaia
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 76(9)
The hepatoprotective action of runihol and S-adenosyl-L-methionine (ademethionine) has been studied in a group of 47 white outbred male rats with model liver injury induced by reserve antituberculosis drugs (PAS, prothionamide, cycloserine). The abil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2655a8a98976f50c5769ee98adf997a9
https://pubmed.ncbi.nlm.nih.gov/24432566
https://pubmed.ncbi.nlm.nih.gov/24432566